Stay updated on ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' appears in the study record history. This replaces the previous 'Revision: v3.6.5' and indicates an additional update to the record.
    Difference
    0.1%
    Check dated 2026-09-01T19:46:18.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the history, replacing v3.6.4, reflecting a software/UI update to the page.
    Difference
    0.1%
    Check dated 2026-08-11T14:59:06.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry (v3.6.4), indicating a page version update. This change affects only the page's metadata and does not modify the study data, conditions, or listings.
    Difference
    0.1%
    Check dated 2026-07-28T04:59:10.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the previous entry v3.6.2 was removed from the list.
    Difference
    0.1%
    Check dated 2026-07-06T18:19:09.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 was added to the study record history, and the previous revision v3.6.0 was removed.
    Difference
    0.1%
    Check dated 2026-06-29T15:51:31.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    A new study version v3.6.0 was posted with a recruitment-status update indicating no longer looking for participants, and the previous version v3.5.5 was removed from the history.
    Difference
    0.4%
    Check dated 2026-06-15T08:42:34.000Z thumbnail image

Stay in the know with updates to ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALKS 4230 and Pembrolizumab in Head and Neck Cancer Clinical Trial page.